Matches in SemOpenAlex for { <https://semopenalex.org/work/W2276089797> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2276089797 endingPage "12" @default.
- W2276089797 startingPage "207" @default.
- W2276089797 abstract "51 SCLC patients who had received prior chemotherapies and had measurable lesions were randomized to CDDP, CDDP-CQ, and CDDP-etoposide treatment group. Prior chemotherapies of 49 complete cases were AVA (ADM, VCR, ACNU; 16 cases), TAVA (THP-ADM, VCR, ACNU; 17 cases), CAV (CPA, ADM, VCR; 4 cases) and others. The median period of 49 cases from prior chemotherapy to this chemotherapy was 4 weeks. In the CDDP alone group, CDDP was given at a dose of 80 approximately 100 mg/m2/4-5 weeks on Day 1, and in CDDP-CQ treatment group, patients were given the same dose of CDDP and CQ 6 mg/body on Day 1, 2. In CDDP-etoposide treatment group, the same doses of CDDP and etoposide 60 mg/m2 Day 1-5 (Total 300 mg/m2) were given. Response rate of the CDDP alone group was 6.7% (PR 1/total 15), that of CDDP-CQ group was 6.3% (PR 1/total 16), and in CDDP-etoposide group it was 16.7% (PR 3/total 18). In CDDP-CQ treatment, the main side effect was strong hematotoxicity (WBC; Grade 3, 5 patients, Grade 4, 2 Pl: Grade 3, 5 Grade 4, 3), and main hematotoxicity of CDDP-etoposide was leukopenia (W BC; Grade 3, 4 patients, Grade 4, 2 Pl; Grade 4, 1). In these patients, it was thought that CDDP was not useful in second chemotherapy, as not only CDDP alone but also the combination with CQ or etoposide." @default.
- W2276089797 created "2016-06-24" @default.
- W2276089797 creator A5002569234 @default.
- W2276089797 creator A5015747301 @default.
- W2276089797 creator A5023160652 @default.
- W2276089797 creator A5031178248 @default.
- W2276089797 creator A5046671291 @default.
- W2276089797 creator A5079429350 @default.
- W2276089797 creator A5080497122 @default.
- W2276089797 creator A5083465797 @default.
- W2276089797 date "1989-02-01" @default.
- W2276089797 modified "2023-09-24" @default.
- W2276089797 title "[A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)]." @default.
- W2276089797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2537605" @default.
- W2276089797 hasPublicationYear "1989" @default.
- W2276089797 type Work @default.
- W2276089797 sameAs 2276089797 @default.
- W2276089797 citedByCount "1" @default.
- W2276089797 crossrefType "journal-article" @default.
- W2276089797 hasAuthorship W2276089797A5002569234 @default.
- W2276089797 hasAuthorship W2276089797A5015747301 @default.
- W2276089797 hasAuthorship W2276089797A5023160652 @default.
- W2276089797 hasAuthorship W2276089797A5031178248 @default.
- W2276089797 hasAuthorship W2276089797A5046671291 @default.
- W2276089797 hasAuthorship W2276089797A5079429350 @default.
- W2276089797 hasAuthorship W2276089797A5080497122 @default.
- W2276089797 hasAuthorship W2276089797A5083465797 @default.
- W2276089797 hasConcept C126322002 @default.
- W2276089797 hasConcept C143998085 @default.
- W2276089797 hasConcept C2776256026 @default.
- W2276089797 hasConcept C2776694085 @default.
- W2276089797 hasConcept C2778119113 @default.
- W2276089797 hasConcept C2780873365 @default.
- W2276089797 hasConcept C71924100 @default.
- W2276089797 hasConcept C90924648 @default.
- W2276089797 hasConceptScore W2276089797C126322002 @default.
- W2276089797 hasConceptScore W2276089797C143998085 @default.
- W2276089797 hasConceptScore W2276089797C2776256026 @default.
- W2276089797 hasConceptScore W2276089797C2776694085 @default.
- W2276089797 hasConceptScore W2276089797C2778119113 @default.
- W2276089797 hasConceptScore W2276089797C2780873365 @default.
- W2276089797 hasConceptScore W2276089797C71924100 @default.
- W2276089797 hasConceptScore W2276089797C90924648 @default.
- W2276089797 hasIssue "2" @default.
- W2276089797 hasLocation W22760897971 @default.
- W2276089797 hasOpenAccess W2276089797 @default.
- W2276089797 hasPrimaryLocation W22760897971 @default.
- W2276089797 hasRelatedWork W1970090775 @default.
- W2276089797 hasRelatedWork W2083033314 @default.
- W2276089797 hasRelatedWork W2276089797 @default.
- W2276089797 hasRelatedWork W2300554255 @default.
- W2276089797 hasRelatedWork W2348340696 @default.
- W2276089797 hasRelatedWork W2399102665 @default.
- W2276089797 hasRelatedWork W2402993451 @default.
- W2276089797 hasRelatedWork W2409349546 @default.
- W2276089797 hasRelatedWork W2412216822 @default.
- W2276089797 hasRelatedWork W2413020017 @default.
- W2276089797 hasVolume "16" @default.
- W2276089797 isParatext "false" @default.
- W2276089797 isRetracted "false" @default.
- W2276089797 magId "2276089797" @default.
- W2276089797 workType "article" @default.